New-Onset Diabetes in COVID-19: Time to Frame Its Fearful Symmetry.
Diabetes Ther
; 12(2): 461-464, 2021 Feb.
Article
in English
| MEDLINE | ID: covidwho-996475
ABSTRACT
There is increasing evidence that coronavirus disease 2019 (COVID-19) may lead to new-onset diabetes mellitus (DM). This may occur even in patients without predisposing factors for impaired glucose metabolism. Both impaired pancreatic insulin secretion and insulin resistance have been implicated as underlying mechanisms. Importantly, new-onset hyperglycaemia is associated with worse prognosis in patients with COVID-19. Indeed, its prognosis may be even more sinister than in patients with pre-existing DM. More research data and knowledge are currently being collected to improve our insights into this constellation and to guide therapies in clinical reality.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Etiology study
/
Prognostic study
Language:
English
Journal:
Diabetes Ther
Year:
2021
Document Type:
Article
Affiliation country:
S13300-020-00988-7
Similar
MEDLINE
...
LILACS
LIS